Professor Hugh Watkins wins £30 million research award to cure killer heart diseases
The British Heart Foundation award aims to help researchers rewrite DNA, in “defining moment” for cardiovascular medicine.
Read moreWe are a large multi-disciplinary department, which aims to tackle some of the world’s biggest health challenges by integrating innovative basic biology with cutting edge clinical research. We have internationally renowned programmes in a range of areas including cardiovascular sciences, diabetes and endocrinology, immunology, haematology and pathology. Find out more about what we do.
Latest Publications
What's new
Biotech spinout MiroBio acquired by Gilead Sciences for ~£332m
5 August 2022
Co-founded by Simon Davis, MiroBio focuses on developing therapeutics for inflammatory diseases.
Professor Hugh Watkins wins £30 million research award to cure killer heart diseases
29 July 2022
The British Heart Foundation award aims to help researchers rewrite DNA, in “defining moment” for cardiovascular medicine.
COVID-19 research
Novel all-in-one vaccine developed to tackle future coronavirus threats
6 July 2022
Up to $30 million in funding has been announced by the Coalition for Epidemic Preparedness Innovations (CEPI) to bring a new nanoparticle vaccine offering protection against a range of coronaviruses to clinical trial.
Building on the pandemic experience
24 May 2022
Dr Susie Shapiro on her experience of working through the pandemic, and how she is building on it.